Black Diamond Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $373k | 98k | 3.79 |
| 2025-06-30 | $244k | 98k | 2.48 |
| 2025-03-31 | $113k | 73k | 1.55 |
| 2024-12-31 | $309k | 145k | 2.14 |
| 2024-09-30 | $649k | 149k | 4.35 |
| 2024-06-30 | $806k | 173k | 4.66 |
| 2024-03-31 | $877k | 173k | 5.07 |
| 2023-09-30 | $363k | 127k | 2.87 |
| 2023-06-30 | $379k | 75k | 5.05 |
| 2023-03-31 | $142k | 75k | 1.89 |
| 2022-12-31 | $225k | 125k | 1.80 |
| 2022-09-30 | $211k | 125k | 1.69 |
| 2022-06-30 | $160k | 65k | 2.45 |
| 2022-03-31 | $214k | 77k | 2.77 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management